CION in the first quarter: the new payout base did not stop the capital erosion

In the first quarter of 2026, CION gave investors a quick and uncomfortable test of the two questions left open after the annual report: whether the new distribution base is really covered, and whether NAV erosion is stopping. The current answer is mixed with a negative tilt: income did not collapse, the portfolio is still mostly first-lien debt, and the company still has access to debt markets, but the quarter did not clean up the story. NII of $0.25 per share did not cover a $0.30 distribution, even after the payout was reduced from the $0.36 quarterly base used in 2025. NAV fell to $13.11 from $13.76 at year-end 2025, and the asset coverage ratio declined to 1.56, moving closer to the 1.50 threshold embedded in the capital structure. The 2031 notes did reduce the JPM balance to $200 million and bought time, but total senior securities rose and Midroog's negative outlook change looks more relevant after the quarter. That makes 2026 less of a recovery year and more of a proof year: the company has to show over the next two to four quarters that recurring income, portfolio value and refinancing can work together instead of pulling in different directions.

The New Payout Base Was Tested, And It Was Not Covered

The move to $0.10 per month was supposed to lower the proof threshold. In the previous distribution-focused analysis, the key checkpoint was simple: can a $0.30 quarterly base be covered by ordinary NII, without an unusually strong fee quarter and without leaning too heavily on non-cash income. The first quarter did not provide that proof. After-tax NII was $12.9 million, or $0.25 per share, against distributions of $15.2 million, or $0.30 per share. On a per-share basis, coverage fell to roughly 0.83x.

That does not mean the distribution is under immediate pressure. The company has already declared $0.10 monthly distributions for both the second and third quarters. But it does mean the reset did not solve the quality question. Total investment income fell to $49.5 million from $56.1 million in the comparable quarter, down 11.7%, mainly because of lower SOFR and a smaller average portfolio. At the same time, interest expense rose to $24.4 million from $23.0 million because average borrowings were higher. Lower rates are therefore helping the liability side only partly, while showing up faster in the revenue line.

There is another layer that the headline NII number does not show. Fee income for the quarter was $2.9 million, and the entire amount came from amendment fees and capital structuring fees, categories that are non-recurring by nature. That line alone equals about 22% of after-tax NII. In addition, paid-in-kind interest and dividends capitalized in the cash flow statement totaled $11.5 million, almost as much as after-tax NII. This does not invalidate the income, but it does require a careful reading of payout coverage: a meaningful part of the accounting income still does not behave like cash received in the same quarter.

Capital Kept Eroding Even Though Marks Were Less Severe

The relatively positive point is that the first quarter of 2026 was less painful than the weak quarters of 2025. The net change in unrealized depreciation was $36.1 million, compared with $64.3 million in the comparable quarter and $59.5 million in the fourth quarter of 2025. But that is a slower pace of damage, not a reversal. Shareholders' equity fell to $659.6 million from $707.6 million, and NAV per share declined 4.7% in one quarter.

The share repurchase program captures the tradeoff well. The company repurchased 1.12 million shares in the quarter at an average price of $8.71, and then bought another 512.6 thousand shares in April at an average price of $7.39. Buying at a deep discount to NAV makes economic sense for the share base, and the financial highlights show a $0.11 contribution to NAV per share from repurchases below NAV. Still, from an all-in cash flexibility perspective, those repurchases used another $9.7 million in a quarter in which NII did not cover the distribution and operating cash flow was negative by $4.6 million.

Portfolio quality also does not give a clean answer. First-lien debt remained 80.8% of the portfolio and equity remained 18.5%, so there was no further structural shift from year-end 2025. On the other hand, internal risk ratings moved in a less comfortable direction: investments rated 1 and 2 fell to 85.0% of the portfolio from 86.1%, while rating 3 rose to 12.9% from 11.5%. Ratings 4 and 5 declined to 2.1% from 2.4%, so this is not evidence of broad portfolio breakdown. The more precise conclusion is that the weakest tail did not worsen, but the portfolio still has not shown the quality rebound needed to stabilize NAV.

The 2031 Debt Bought Time, But The Coverage Ratio Says Not To Overstate It

One question left open after the 2031 notes analysis was how much pressure actually came off JPM. The quarter gave a partial answer: the company issued $135 million of 7.50% notes due 2031 and used the proceeds to repay borrowings under JPM. At both March 31 and April 29, the JPM balance stood at $200 million, down from $300 million at year-end 2025. That is real progress because it reduces secured debt and extends maturity.

But that progress is not enough to make the capital structure comfortable. Total senior securities rose to $1.175 billion from $1.140 billion at year-end 2025 because the company issued $135 million and repaid $100 million. The asset coverage ratio fell to 1.56 from 1.62, meaning the cushion above the 1.50 floor shrank from roughly 8% to roughly 4%. That is the number tying the quarter to Midroog's April 2026 decision to change the rating outlook from stable to negative: the issue is not only weaker profitability, but a regulatory cushion that keeps narrowing.

Liquidity is still available. At the end of March the company had $9.2 million of cash, $97.1 million of short-term investments and another $100 million available under its secured facilities. Against that, however, stand $114.8 million of Series A notes due in August 2026 and roughly $527.5 million of 2027 maturities after the reduction in JPM. As long as NAV and asset coverage continue to fall, the market is unlikely to stop at the statement that near-term liquidity is sufficient. It will want evidence that the company can move through 2026 without weakening the cushion it needs before 2027.

What Will Decide 2026

The first quarter did not break CION, but it also did not clean up the picture. The current conclusion is that this BDC still produces income, but the new payout base already needs another proof point, and shareholders' equity continues to absorb the cost of marks, leverage and capital allocation. The next few quarters need to show NII of at least $0.30 per share without an unusual fee spike, a halt in NAV erosion, and debt management that does not push the asset coverage ratio closer to 1.50.

There is also a reasonable counter-thesis: the market may be too harsh. Most of the portfolio remains first-lien debt, ratings 4 and 5 did not worsen in the quarter, the company accessed long-term unsecured debt, and repurchases at a deep discount create NAV per share value if marks stabilize. For that argument to win, though, Q2 and Q3 need to look different from Q1. If a 100 basis point decline in rates is expected to reduce annual NII by about $4.9 million, and if every additional portfolio mark matters more with the asset coverage ratio already at 1.56, then 2026 will be judged less by the fact that distributions continue and more by whether distributions, buybacks and debt can coexist without further capital erosion.